Human Genetics Market Synopsis

Human Genetics Market Size is Valued at USD 31.79 Billion in 2023 and is Projected to Reach USD 72.22 Billion by 2032, Growing at a CAGR of 10.80% From 2024-2032.

The Human Genetics Market is defined as the market in the human genetics field of research and development of genetically based diseases and conditions diagnostics as well as management. This market involves genetic test kits and services, genetic counselors, research instruments, and applications including DNA sequencing and gene editing. It works in oncology, cardiology, neurology, and the field of study of the individual, and thus affect hospitals, research laboratory, diagnostic center, and drug company across the world. The market strives to bring the concept of precision medicine into practice and enhance the care of genetic disorders.

• For Human Genetics Market, the growth is steady – though fast – as the better identification tools are developed and the people’s understanding of genetic differences broadens. Molecular techniques including NGS and gene editing technology like CRISPR/Cas9 have drastically boosted the discovery of Genetic diseases, and record diagnosing of the same. The market for genetic testing and counseling services continues to grow because of its crucial importance in cancer, heart, and genetic disorders diagnosis. Also, attempts of widening Genetic databases and research instruments, are helping the creation of new therapeutic options and unique approaches to the treatment of individual patient cases.
• In terms of location, the market is growing consistently within North America, Europe, Asia-Pacific, among others; all of which play a role in the progression of genetics proficiency and therapy. North America holds the largest market share that can be attributed to developed healthcare facilities within the region coupled with highly committed funding in the field of genetics. On the other hand, Asia-Pacific region is expected to show a fairly good growth due to higher healthcare spending and development of genomics strategies. Indeed, with the increasing proportions of the global population’s focus on personal health and the gradual advancements in the areas of genetic study, the Human Genetics Market is likely to be a constant market that continues to grow and innovate.

Human Genetics Market Trend Analysis

Unlocking the Potential of Human Genetics, Market Trends and Technological Advancements

• Owing to the advancements in genomics technology, the Human Genetics Market is rapidly growing and has expanded substantially due to the request of individualized treatments. The utilization of Next-Generation Sequencing (NGS) and CRISPR/Cas9 gene editing technologies is the trend that defines the development of field and the catalogue of further genetic studies and practices. This growth is attributed to increased stringer of genetic disorders, availability and popularity of genetic testing kits and services and shift towards preventive genetic health care. Moreover, incorporation of artificial intelligence and big data in genetic study is also improving the accuracy in identifying the genetic tests and diagnosing the genetic disorders.
• Location wise, North America and Europe are dominating the market due to its strong connectivity in the medical sectors, numerous investments made on research aspect, and higher incidence of genetic disorders. However, the Asia-Pacific is stepping forward as a more potent region owing to a rising health care capacity, doing more expenditure on health, and a new focus on gene research. As the market continues to dynamically, there are indications that organizations such as universities, hospitals, and genetic firms are working together to enhance genetic research and enhance patients’ quality of life.

Innovations Driving Growth in the Human Genetics Market

• The Human Genetics Market is highly emerging because of the technological enhancements in the field of genetics and an increasing awareness of people regarding genomic medicine. Advancements in molecular techniques such as Next Generation Sequencing as well as other techniques which are more advanced are leading to precision testing at a cheaper cost. This progress is creating better opportunities for seminal developments in diagnostics, treatment and disease prevention. The advancements in the usage of genetic test especially in oncology, cardiology and rare diseases are helping in increasing the market demand. Also, the ascendance of the personalized medicine and precision healthcare concept is inspiring significant business opportunities for suppliers of genetic testing services and goods based on individual DNA.
• In addition, the increasing number of genetic disorders and people have shifted toward early detection and precautionary measures, are some few factors boosting the growth of the market. The implication of genetic research tools and databases in the clinical practices and research settings is making it easier to identify genetic risks and to develop specific treatment strategies. A little literature also exists about the aiding of the market by governmental policies and financial support to genetic researches and healthcare enhancement. Therefore, it can be concluded that in the further development of the human genetics field and constant technological enhancements regardless of the negative side of genetics the business opportunities seem to be vast in meeting the developing demands for genetic information and individualized healthcare services.

Human Genetics Market Segment Analysis:

Human Genetics Market Segmented on the basis of type, Technology, application, and end-users.

By Product Type, Genetic Testing Kits segment is expected to dominate the market during the forecast period

• The Human Genetics Market is segmented by product type into several key categories: Genetic Testing Kits that are used in different kinds of genetic analysis and diagnostics; Genetic Testing Services that offer professional testing and analysis of genetic data; Genetic Counseling Services giving professional consultation and support to patients and Genetic Databases that store and manage large amounts of genetic data for research and clinical application; Genetic Research Instruments that are necessary for genetic research and creation of new testing equipment. All the segments are very important in the enhancement of genetic knowledge and achievement of genetic medicine.

By Application, Oncology segment held the largest share in 2024

• The Human Genetics Market is segmented by application into various specialized areas: Specialties include Oncology, Genetics in Cancer and Targeted therapy; Cardiology, Hereditary Factors in Cardiovascular Diseases; Neurology, genetic aspects of neurological disorders; Pediatrics, Genetic disorders affecting children; Obstetrics and Gynecology, Genetic test in reproductive health; Rare Diseases, Genetic disorders of low incidence; Personalized medicine, treatments based on an individual’s genetic makeup; Prenatal diagnostics; and its application in Forensics. All applications bring a positive result to the broad spectrum and the constantly developing wave of genetic technologies in medicine.

Human Genetics Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• The human genetic market of North America is considered as one of the most prominent and the most developed one of its kind as it has increased research investment and well-developed healthcare infrastructure accompanied with high acceptance of genetic technologies. Major countries include the United States and Canada; the former dominates the market because of its highly developed health care sector, numerous and well-equipped diagnostic facilities, and active genetic research. The region enjoys an advantageous position of relatively higher occurrence of genetic disorders, enhanced awareness and the progressing demand for personalized form of treatment, thus, fuelling the market growth.
• Another factor is the objective achievements of innovative processes, like Next-Generation Sequencing (NGS) and CRISPR/Cas9 gene editing, have made North America a home of some of the best biotech companies and universities. Other key factors are the availability of large numbers of market players, constant technological advancement, and favourable government policies regarding genetic diagnosis and treatment. It is found that the region’s market has been investing a lot in genetic technology and related R&D, which will play a role towards the future growth and expansion in human genetics.

Active Key Players in the Human Genetics Market

• Illumina, Inc. (United States)
• Thermo Fisher Scientific, Inc. (United States)
• Abbott Laboratories (United States)
• Agilent Technologies, Inc. (United States)
• Bio-Rad Laboratories, Inc. (United States)
• QIAGEN N.V. (Netherlands)
• Genomic Health, Inc. (United States)
• Natera, Inc. (United States)
• Myriad Genetics, Inc. (United States)
• Eurofins Scientific SE (Luxembourg)
• MedGenome Labs (India)
• Invitae Corporation (United States)
• Helix (United States)
• Fulgent Genetics, Inc. (United States)
• PathAI (United States), Others

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Human Genetics Market by Type
 4.1 Human Genetics Market Snapshot and Growth Engine
 4.2 Human Genetics Market Overview
 4.3 Men Shoes
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Men Shoes: Geographic Segmentation Analysis
 4.4 Women Shoes
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Women Shoes: Geographic Segmentation Analysis

Chapter 5: Human Genetics Market by Application
 5.1 Human Genetics Market Snapshot and Growth Engine
 5.2 Human Genetics Market Overview
 5.3 Adults
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Adults: Geographic Segmentation Analysis
 5.4 Children
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Children: Geographic Segmentation Analysis

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Benchmarking
  6.1.2 Human Genetics Market Share by Manufacturer (2023)
  6.1.3 Industry BCG Matrix
  6.1.4 Heat Map Analysis
  6.1.5 Mergers and Acquisitions
  
 6.2 ILLUMINA INC (UNITED STATES)
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Role of the Company in the Market
  6.2.5 Sustainability and Social Responsibility
  6.2.6 Operating Business Segments
  6.2.7 Product Portfolio
  6.2.8 Business Performance
  6.2.9 Key Strategic Moves and Recent Developments
  6.2.10 SWOT Analysis
 6.3 THERMO FISHER SCIENTIFIC INC (UNITED STATES)
 6.4 ABBOTT LABORATORIES (UNITED STATES)
 6.5 AGILENT TECHNOLOGIES INC (UNITED STATES)
 6.6 BIO-RAD LABORATORIES INC (UNITED STATES)
 6.7 QIAGEN NV (NETHERLANDS)
 6.8 GENOMIC HEALTH INC (UNITED STATES)
 6.9 NATERA INC (UNITED STATES)
 6.10 MYRIAD GENETICS INC (UNITED STATES)
 6.11 EUROFINS SCIENTIFIC SE (LUXEMBOURG)
 6.12 MEDGENOME LABS (INDIA)
 6.13 INVITAE CORPORATION (UNITED STATES)
 6.14 HELIX (UNITED STATES)
 6.15 FULGENT GENETICS INC (UNITED STATES)
 6.16 PATHAI (UNITED STATES)
 6.17 OTHERS

Chapter 7: Global Human Genetics Market By Region
 7.1 Overview
 7.2. North America Human Genetics Market
  7.2.1 Key Market Trends, Growth Factors and Opportunities
  7.2.2 Top Key Companies
  7.2.3 Historic and Forecasted Market Size by Segments
  7.2.4 Historic and Forecasted Market Size By Type
   7.2.4.1 Men Shoes
   7.2.4.2 Women Shoes
  7.2.5 Historic and Forecasted Market Size By Application
   7.2.5.1 Adults
   7.2.5.2 Children
  7.2.6 Historic and Forecast Market Size by Country
   7.2.6.1 US
   7.2.6.2 Canada
   7.2.6.3 Mexico
 7.3. Eastern Europe Human Genetics Market
  7.3.1 Key Market Trends, Growth Factors and Opportunities
  7.3.2 Top Key Companies
  7.3.3 Historic and Forecasted Market Size by Segments
  7.3.4 Historic and Forecasted Market Size By Type
   7.3.4.1 Men Shoes
   7.3.4.2 Women Shoes
  7.3.5 Historic and Forecasted Market Size By Application
   7.3.5.1 Adults
   7.3.5.2 Children
  7.3.6 Historic and Forecast Market Size by Country
   7.3.6.1 Bulgaria
   7.3.6.2 The Czech Republic
   7.3.6.3 Hungary
   7.3.6.4 Poland
   7.3.6.5 Romania
   7.3.6.6 Rest of Eastern Europe
 7.4. Western Europe Human Genetics Market
  7.4.1 Key Market Trends, Growth Factors and Opportunities
  7.4.2 Top Key Companies
  7.4.3 Historic and Forecasted Market Size by Segments
  7.4.4 Historic and Forecasted Market Size By Type
   7.4.4.1 Men Shoes
   7.4.4.2 Women Shoes
  7.4.5 Historic and Forecasted Market Size By Application
   7.4.5.1 Adults
   7.4.5.2 Children
  7.4.6 Historic and Forecast Market Size by Country
   7.4.6.1 Germany
   7.4.6.2 UK
   7.4.6.3 France
   7.4.6.4 Netherlands
   7.4.6.5 Italy
   7.4.6.6 Russia
   7.4.6.7 Spain
   7.4.6.8 Rest of Western Europe
 7.5. Asia Pacific Human Genetics Market
  7.5.1 Key Market Trends, Growth Factors and Opportunities
  7.5.2 Top Key Companies
  7.5.3 Historic and Forecasted Market Size by Segments
  7.5.4 Historic and Forecasted Market Size By Type
   7.5.4.1 Men Shoes
   7.5.4.2 Women Shoes
  7.5.5 Historic and Forecasted Market Size By Application
   7.5.5.1 Adults
   7.5.5.2 Children
  7.5.6 Historic and Forecast Market Size by Country
   7.5.6.1 China
   7.5.6.2 India
   7.5.6.3 Japan
   7.5.6.4 South Korea
   7.5.6.5 Malaysia
   7.5.6.6 Thailand
   7.5.6.7 Vietnam
   7.5.6.8 The Philippines
   7.5.6.9 Australia
   7.5.6.10 New Zealand
   7.5.6.11 Rest of APAC
 7.6. Middle East & Africa Human Genetics Market
  7.6.1 Key Market Trends, Growth Factors and Opportunities
  7.6.2 Top Key Companies
  7.6.3 Historic and Forecasted Market Size by Segments
  7.6.4 Historic and Forecasted Market Size By Type
   7.6.4.1 Men Shoes
   7.6.4.2 Women Shoes
  7.6.5 Historic and Forecasted Market Size By Application
   7.6.5.1 Adults
   7.6.5.2 Children
  7.6.6 Historic and Forecast Market Size by Country
   7.6.6.1 Turkey
   7.6.6.2 Bahrain
   7.6.6.3 Kuwait
   7.6.6.4 Saudi Arabia
   7.6.6.5 Qatar
   7.6.6.6 UAE
   7.6.6.7 Israel
   7.6.6.8 South Africa
 7.7. South America Human Genetics Market
  7.7.1 Key Market Trends, Growth Factors and Opportunities
  7.7.2 Top Key Companies
  7.7.3 Historic and Forecasted Market Size by Segments
  7.7.4 Historic and Forecasted Market Size By Type
   7.7.4.1 Men Shoes
   7.7.4.2 Women Shoes
  7.7.5 Historic and Forecasted Market Size By Application
   7.7.5.1 Adults
   7.7.5.2 Children
  7.7.6 Historic and Forecast Market Size by Country
   7.7.6.1 Brazil
   7.7.6.2 Argentina
   7.7.6.3 Rest of SA

Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies

Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research